| Financial Year |
March 31 2023 |
| Monetary Funds |
254,786,396.52 |
| Held-for-trading Financial Assets |
60,000,000.00 |
| Notes Receivable |
300,000.00 |
| Accounts Receivable |
302,507,518.83 |
| Advances to Suppliers |
42,340,153.48 |
| Other Receivables |
3,054,891.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
331,957,925.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,212,714.78 |
| Total Current Assets |
1,045,989,440.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
138,195,680.81 |
| Under-construction Projects |
67,647,332.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,945,456.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
869,961.92 |
| Deferred Income Tax Assets |
12,405,568.32 |
| Other Non-Current Assets |
160,193,950.01 |
| Sub-Total of Non-Current Assets |
391,257,949.93 |
| Total Assets |
1,437,247,389.95 |
| Short-Term Loans |
1,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,000,000.00 |
| Accounts Payable |
15,481,186.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,711,976.67 |
| Taxes Payable |
11,987,120.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,367,716.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
199,932,671.92 |
| Long-term Loans |
1,070,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
74,231,276.42 |
| Deferred Income Tax Liabilities |
5,632,927.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,685,953.42 |
| Total Liabilities |
281,618,625.34 |
| Paid-In Capital(Or Share Stock) |
137,793,000.00 |
| Capital Surplus |
482,343,291.08 |
| Surplus Reserve |
18,640,285.53 |
| LESS:Treasury Stock |
25,566,980.00 |
| Undistributed Profits |
542,419,168.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,155,628,764.61 |
| Owner's Equity（Stockholder's Equity） |
1,155,628,764.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,437,247,389.95 |
